MetLife Inc 5.625% Series E Preferred Stock
MET.PRE
4 hedge funds and large institutions have $971K invested in MetLife Inc 5.625% Series E Preferred Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0.94% less ownership
Funds ownership: 1.07% → 0.13% (-0.94%)
20% less funds holding
Funds holding: 5 → 4 (-1)
88% less capital invested
Capital invested by funds: $8.09M → $971K (-$7.12M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CGH
Crossmark Global Holdings
Houston,
Texas
|
-$7.12M |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.44K |
MET.PRE Hedge Fund Activity: Q1 2025 in Review
4 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q1 2025, worth a combined $971K — down 88% from $8.09M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MET.PRE and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Crossmark Global Holdings, exiting entirely with an estimated $7.12M sold.
- 4 institutional investors held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q1 2025, down from 5 in Q4 2024.
- Funds reported $971K of MetLife Inc 5.625% Series E Preferred Stock stock for Q1 2025, down 88% quarter-over-quarter.
- 0 funds opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q1 2025 and 1 closed out, a net change of -1 holder.
- The largest MetLife Inc 5.625% Series E Preferred Stock seller in Q1 2025 was Crossmark Global Holdings, an estimated $7.12M sold.
Based on aggregated 13F filings for Q1 2025.